The Compass can help you find your way in PEAK, but is it really worth carrying? Here’s a look at the pros and cons.

Compass Pathways' Phase 3 COMP-360 data met primary endpoints but disappointed vs analyst expectations. See why investors ...

Compass Pathways plc downgraded to Hold after mixed trial results. Explore upcoming catalysts in depression treatment and ...

Compass Pathways Plc’s shares plummeted after its psychedelic drug to treat a form of depression disappointed investors in a ...

Although the company withheld detailed findings from the study of treatment-resistant depression, analysts at Stifel called ...

Compass Pathways' COMP005 trial met its primary endpoint in TRD, but modest results sparked a 47% drop in shares amid ...

While positive, results from a late-stage clinical trial appear to be raising questions about how useful the company’s ...

Should home sellers and their agents be allowed to market listings privately, or should they be required to make listings viewable on all platforms right away?

Fintel reports that on June 9, 2025, Compass Point downgraded their outlook for Applied Digital (NasdaqGS:APLD) from Buy to Neutral. Analyst Price Forecast Suggests 20.54% Downside As of June 1 ...

While Compass Point doesn’t expect a full replay of the 2020–21 Altcoin boom, they noted, “Alts typically rebound as BTC approaches new highs,” leaving room for a tactical rally that could temporarily ...

Compass Point slashed Marathon’s price target to $9.50, warning of dilution and premium bitcoin exposure. By Helene Braun | Edited by Stephen Alpher Updated May 6, 2025, 4:28 p.m. Published May ...

WASHINGTON, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Compass Point Research & Trading, LLC ('Compass Point”), a leading middle market investment bank, is pleased to announce its partnership with Sea Court ...